Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Cash from Operations (2019 - 2026)

Alx Oncology Holdings' Cash from Operations history spans 5 years, with the latest figure at 39678000.0 for Q4 2023.

  • On a quarterly basis, Cash from Operations fell 91.98% to 39678000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was 130364000.0, a 46.11% decrease, with the full-year FY2025 number at 84142000.0, up 30.98% from a year prior.
  • Cash from Operations hit 39678000.0 in Q4 2023 for Alx Oncology Holdings, down from 31159000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for ALXO hit a ceiling of 2874000.0 in Q4 2019 and a floor of 39678000.0 in Q4 2023.
  • Historically, Cash from Operations has averaged 18446500.0 across 5 years, with a median of 19055000.0 in 2021.
  • Biggest five-year swings in Cash from Operations: plummeted 373.73% in 2020 and later skyrocketed 42.71% in 2021.
  • Tracing ALXO's Cash from Operations over 5 years: stood at 2874000.0 in 2019, then plummeted by 373.73% to 13615000.0 in 2020, then dropped by 28.45% to 17488000.0 in 2021, then fell by 18.18% to 20668000.0 in 2022, then plummeted by 91.98% to 39678000.0 in 2023.
  • Business Quant data shows Cash from Operations for ALXO at 39678000.0 in Q4 2023, 31159000.0 in Q3 2023, and 31711000.0 in Q2 2023.